News




CARIS & COMPANY AND M.M. DILLON & CO.
FORM JOINT VENTURE


            San Diego, CA March 2, 2011– Caris & Company and M.M. Dillon & Co. announced today that the two Wall Street firms have formed a joint venture, Caris Dillon, exclusively pairing Caris’ award winning research with Dillon’s world class Investment Banking and Advisory team. This unique strategic alliance is designed to benefit growth companies and investors in the critical capital formation cycle.

            “The team at Dillon has long been heralded as one of Wall Street’s premier advisory groups. The ethics, pedigree, domain expertise, and relationships that comprise the fabric of Dillon make for a perfect complement to our research oriented business,” said Darren Caris, Chairman and CEO of Caris. “Our goal is to expand both of our platforms to bring our corporate and institutional clients a new level of depth of service; objective in our advice, unparalleled in our industry and market knowledge, highly focused on the markets that we serve and, importantly, with a global reach. We will with Caris Dillon be the boutique alternative to the bulge bracket.” Mr. Caris added that the two firms plan to fill a massive void on Wall Street by offering a highly ethical, concentrated, yet comprehensive solution to institutional clients looking for independent advice and corporate clients who desire comprehensive solutions to their capital formation and advisory needs.

            Dillon Chairman and CEO, Michiel McCarty, added “I have worked to build multiple boutiques in my 35 years on Wall Street and the opportunity with Caris Dillon excites me more than all the others combined. Caris has perfected the truly independent focused research platform in a manner unseen for 25 years, creating a must read analysis for institutional investors in technology and healthcare. Dillon’s success in becoming a trusted advisor to CEOs and boards in these two important sectors of healthcare and technology perfectly complements the Caris research-centric platform. The ultimate beneficiaries of this unique blend of two unbiased providers of critical advice will be the growth companies desperately in need of capital and their providers the institutional investors.”

            Mr. McCarty added, “Wall Street has evolved over the last few decades into giant monolithic institutions that are designed principally for the benefit of themselves rather than for the enhancement of their clients. I view this new venture, Caris Dillon, as a unique combined platform designed and implemented to bring the focus back to the capital formation mechanism for growth companies so important for our economy. In a way, this Caris Dillon venture is returning to the original roots of investment banking as practiced by such luminaries as: Sigmund Warburg, Clarence Dillon, Bill Hambrecht and Sandy Robertson.”

# #



About Caris & Company

Established in 2002, Caris & Company is a full service investment bank that services Wall Street’s institutional investment community by providing differentiated, collaborative, alpha-generating ideas. Headquartered in San Diego, CA, Caris & Company has offices in New York, San Francisco, and Boston. The firm’s research product includes coverage in the following areas: Pharmaceuticals, Specialty Pharma, Biotechnology, Medical Devices, Medical Diagnostics, Healthcare IT, Semiconductors, Semi-Cap Equipment, Hardware, Storage, Media, and Specialty Retail. www.cariscompany.com.

About M.M. Dillon & Co.

Established in 2003, M.M. Dillon & Co.is a full service investment bank that provides the complete spectrum of services to growth companies including merger advisory, restructuring and capital raising. The firm consists of 14 senior partners from major bracket investment banks with average experience in the industry of over 24 years and a full complement of execution staff. The firm was originally founded as the investment banking arm of CRT Capital Group from which it was spun out in January 2009. The firm’s partners focus upon industries in need of capital: Biotechnology, Specialty Pharmaceuticals, Healthcare Services, Technology, Media, Telecom, Automotive and Consumer. www.mmdillon.com.

Media Contacts:

Judy Jeub
jjeub@cariscompany.com
858-704-0311

Mike McCarty
mmccarty@mmdillon.com
646-286-6628